These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26272590)
1. Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy. Kim SH; Park WS; Yun SI; Joo J; Joung JY; Seo HK; Chung J; Lee GK; Lee KH Histopathology; 2016 Apr; 68(5):673-9. PubMed ID: 26272590 [TBL] [Abstract][Full Text] [Related]
2. PSCA, Cox-2, and Ki-67 are independent, predictive markers of biochemical recurrence in clinically localized prostate cancer: a retrospective study. Kim SH; Park WS; Park BR; Joo J; Joung JY; Seo HK; Chung J; Lee KH Asian J Androl; 2017; 19(4):458-462. PubMed ID: 27232854 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy. Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981 [TBL] [Abstract][Full Text] [Related]
5. Akt Activation Correlates with Snail Expression and Potentially Determines the Recurrence of Prostate Cancer in Patients at Stage T2 after a Radical Prostatectomy. Chen WY; Hua KT; Lee WJ; Lin YW; Liu YN; Chen CL; Wen YC; Chien MH Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27455254 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy. Li T; Huang S; Dong M; Gui Y; Wu D Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540 [TBL] [Abstract][Full Text] [Related]
7. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy. Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270 [TBL] [Abstract][Full Text] [Related]
8. TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy. Raatikainen S; Aaltomaa S; Palvimo JJ; Kärjä V; Soini Y Scand J Urol; 2015 Feb; 49(1):51-7. PubMed ID: 24779451 [TBL] [Abstract][Full Text] [Related]
9. Do Second Primary Cancers Affect the Risk of Biochemical Recurrence in Prostate Cancer Patients Undergoing Radical Prostatectomy? A Propensity Score-Matched Analysis. Kang M; Jung JW; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS Clin Genitourin Cancer; 2016 Aug; 14(4):e363-9. PubMed ID: 27105723 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer. Kim SH; Kim SH; Joung JY; Lee GK; Hong EK; Kang KM; Yu A; Nam BH; Chung J; Seo HK; Park WS; Lee KH PLoS One; 2015; 10(4):e0122498. PubMed ID: 25897494 [TBL] [Abstract][Full Text] [Related]
11. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome. De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296 [TBL] [Abstract][Full Text] [Related]
12. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136 [TBL] [Abstract][Full Text] [Related]
13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [TBL] [Abstract][Full Text] [Related]
14. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence. O'Neil LM; Walsh S; Cohen RJ; Lee S BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868 [TBL] [Abstract][Full Text] [Related]
15. Increased nuclear factor erythroid 2-related factor 2 expression predicts worse prognosis of prostate cancer patients treated with radical prostatectomy. Raatikainen S; Aaltomaa S; Kärjä V; Soini Y Hum Pathol; 2014 Nov; 45(11):2211-7. PubMed ID: 25175169 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis. Tae BS; Cho S; Kim HC; Kim CH; Kang SH; Lee JG; Kim JJ; Park HS; Cheon J; Oh MM; Kang SG Sci Rep; 2018 Jul; 8(1):10748. PubMed ID: 30013089 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of pathologic prostate-specific antigen mass ratio in patients with localized prostate cancer with negative surgical resection margins. Lee S; Jeong CW; Jeong SJ; Hong SK; Choi W; Byun SS; Lee SE Urology; 2013 Oct; 82(4):865-9. PubMed ID: 23830078 [TBL] [Abstract][Full Text] [Related]
20. Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy. Kim SH; Park WS; Kim SH; Park B; Joo J; Lee GK; Joung JY; Seo HK; Chung J; Lee KH PLoS One; 2016; 11(3):e0151646. PubMed ID: 26982980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]